Unusual Presentation of Denys-Drash Syndrome in a Girl with Undisclosed Consumption of Biotin
Authors:
- Carla BizzarriCBCarla Bizzarri
- Germana Antonella GiannoneGGGermana Antonella Giannone
- Jacopo GervasoniJGJacopo Gervasoni
- Sabina BenedettiSBSabina Benedetti
- Federica AlbaneseFAFederica Albanese
- Luca Dello StrologoLSLuca Dello Strologo
- Isabella GuzzoIGIsabella Guzzo
- Mafalda MuccioloMMMafalda Mucciolo
- Francesca Diomedi CamasseiFCFrancesca Diomedi Camassei
- Francesco EmmaFEFrancesco Emma
- Marco CappaMCMarco Cappa
- Ottavia PorzioOPOttavia Porzio
Open Access
- 23 August 2021
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 13 (3) , 347-352
Abstract
We describe a 46,XX girl with Denys-Drash syndrome, showing both kidney disease and genital abnormalities, in whom a misdiagnosis of hyperandrogenism was made. A 15 year-old girl was affected by neonatal nephrotic syndrome, progressing to end stage kidney failure. Hair loss and voice deepening were noted during puberty. Pelvic ultrasound and magnetic resonance imaging showed utero-tubaric agenesis, vaginal atresia and urogenital sinus, with inguinal gonads. Gonadotrophin and estradiol levels were normal, but testosterone was increased up to 285 ng/dL at Tanner stage 3. She underwent prophylactic gonadectomy. Histopathology reported fibrotic ovarian cortex containing numerous follicles in different maturation stages and rudimental remnants of Fallopian tubes. No features of gonadoblastoma were detected. Unexpectedly, testosterone levels were elevated four months after gonadectomy (157 ng/dL). Recent medical history revealed chronic daily comsumption of high dose biotin, as a therapeutic support for hair loss. Laboratory immunoassay instruments used streptavidin-biotin interaction to detect hormones and, in competitive immunoassays, high concentrations of biotin can result in false high results. Total testosterone, measured using liquid chromatography tandem mass spectrometry, was within reference intervals. Similar testosterone levels were detected on repeat immunoassay two weeks after biotin uptake interruption. Discordance between clinical presentation and biochemical results in patients taking biotin, should raise the suspicion of erroneous results. Improved communication among patients, health care providers, and laboratory professionals is required concerning the likelihood of biotin interference with immunoassays.Keywords
This publication has 14 references indexed in Scilit:
- Refining the Diagnosis of Congenital Nephrotic Syndrome on Long-term Stored Tissue: c.1097G>A (p.(Arg366His)) WT1 Mutation Causing Denys Drash SyndromeFetal and Pediatric Pathology, 2016
- Wt1 directs the lineage specification of sertoli and granulosa cells by repressing Sf1 expressionDevelopment, 2016
- Novel WT1 Missense Mutations in Han Chinese Women with Premature Ovarian FailureScientific Reports, 2015
- Genetic Basis of Congenital and Infantile Nephrotic SyndromesAmerican Journal of Kidney Diseases, 2011
- Denys–Drash syndrome and congenital diaphragmatic hernia: Another case with the 1097G > A(Arg366His) mutationAmerican Journal of Medical Genetics Part A, 2008
- Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defectPediatric Nephrology, 2006
- Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twinsPediatric Nephrology, 2001
- Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndromeCell, 1991
- WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumourNature, 1991
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990